RxDoctor Payments Data

Elizabeth Bucher, MD

MOHS-Micrographic Surgery · Metairie, LANPI 1295995546

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Mimedx Group, Inc. at 55.2% of the total. 2025 is the largest year on record at $225, 4.3 times the $52 reported in 2019.

$442in general payments, 2019–2025

Across 26 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$244
  • E.r. Squibb & Sons, L.L.C.$112
  • Genentech USA, Inc.$68
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$18

What the payments were for

  • Food & beverage$442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$412,595
Medicare patients
341
Services billed
1,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin114$914
Doxycycline Monohydrate19$184
Amoxicillin25$33
Tramadol Hcl19$17

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →